Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Carisma Therapeutics Inc. (SESN) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $2.33 Metrics
OS: 40.3 M -47 % ROE
Market cap: $93.9 M
Net cash: $117 M $2.91 per share
EV:

 
TTM Valuation
EBITDA ($21.6) M
EBIT ($23.0) M
EPS ($2.35)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues40.026.511.20.00.00.430.01.0
            Revenue growth50.7%136.2%  -100.0%-98.6%2928.4%-55.9%
Cost of goods sold-117.9-91.9-43.50.00.00.0-28.20.0
Gross profit157.9118.554.70.00.00.458.21.0
            Gross margin394.8%446.3%487.1%  100.0%194.1%100.0%
Research and development38.625.329.224.714.112.513.526.3
General and administrative39.829.414.312.211.68.114.79.9
EBIT-38.4-28.2-32.3-36.9-25.7-20.22.9-35.2
            EBIT margin-96.0%-106.1%-287.1%  -4742.4%9.6%-3555.2%
Pre-tax income-23.8-8.6-21.0-107.5-33.7-29.01.9-33.5
Income taxes3.98.3-1.40.00.00.00.00.0
            Tax rate  6.9%0.0%0.0%0.0%0.3%0.0%
Net income-19.9-0.3-22.5-107.5-33.7-29.01.9-33.5
            Net margin-49.7%-1.3%-200.6%  -6830.4%6.3%-3379.0%
 
Diluted EPS($0.10)$0.00($0.19)($1.18)($0.55)($1.11)$0.09($1.76)
Shares outstanding (diluted)200.5182.3118.290.961.826.121.719.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy